Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongmai Yangxin Pill for premature atrial contraction with qi and yin deficiency syndrome
ChiCTR1900025768Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Sep 2019
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Tongmai Yangxin Pills in atrial extrasystole (AES) (2 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: 24-hour dynamic electrocardiogram. Started Sep 2019; status: recruiting.
02
Drugs
Tongmai Yangxin Pills
03
Conditions
atrial extrasystole (AES)
Beyond the preview
Go deeper on ChiCTR1900025768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025768.